Rezultati - Lodise, Thomas

Refine Results
  1. 1
    1439. Epidemiology and 12- Month Antibiotic Use in the Outpatient Setting among Adult Patients with Complicated Urinary Tract Infections: A Retrospective Database Analysis

    1439. Epidemiology and 12- Month Antibiotic Use in the Outpatient Setting among Adult Patients with Complicated Urinary Tract Infections: A Retrospective Database Analysis od Lodise, Thomas, Lodise, Thomas, Manjelievskaia, Janna, Brouillette, Matthew, Sulham, Kate

    Izdano 2021
    Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    1462. Hospital Admission Patterns in Adult Patients with Community-Acquired Bacterial Pneumonia Who Received Ceftriaxone and a Macrolide by Pneumonia Severity Index Score

    1462. Hospital Admission Patterns in Adult Patients with Community-Acquired Bacterial Pneumonia Who Received Ceftriaxone and a Macrolide by Pneumonia Severity Index Score od Lodise, Thomas, LaPensee, Ken

    Izdano 2018
    Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Potential Cost-Savings with Once-Daily Aminomethylcycline Antibiotic versus Vancomycin in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections

    Potential Cost-Savings with Once-Daily Aminomethylcycline Antibiotic versus Vancomycin in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections od LaPensee, Ken, Lodise, Thomas

    Izdano 2018
    Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Cost-Saving Opportunities with an Oral and Intravenous Once-Daily Aminomethylcycline Antibiotic for Hospitalized Patients with Community-Acquired Bacterial Pneumonia: Findings from Decision-Analytic Models

    Cost-Saving Opportunities with an Oral and Intravenous Once-Daily Aminomethylcycline Antibiotic for Hospitalized Patients with Community-Acquired Bacterial Pneumonia: Findings from... od Lodise, Thomas, LaPensee, Kenneth

    Izdano 2019
    Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Response to the Letter to the Editor Regarding “Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies” [Response to Letter]

    Response to the Letter to the Editor Regarding “Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Compari... od Lodise, Thomas P, Sethi, Sanjay

    Izdano 2021
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Steady-State Plasma Pharmacokinetics of Oral Voriconazole in Obese Adults

    Steady-State Plasma Pharmacokinetics of Oral Voriconazole in Obese Adults od Pai, Manjunath P., Lodise, Thomas P.

    Izdano 2011
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Oseltamivir and Oseltamivir Carboxylate Pharmacokinetics in Obese Adults: Dose Modification for Weight Is Not Necessary

    Oseltamivir and Oseltamivir Carboxylate Pharmacokinetics in Obese Adults: Dose Modification for Weight Is Not Necessary od Pai, Manjunath P., Lodise, Thomas P.

    Izdano 2011
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Ceftaroline Fosamil for the Treatment of Community-Acquired Pneumonia: from FOCUS to CAPTURE

    Ceftaroline Fosamil for the Treatment of Community-Acquired Pneumonia: from FOCUS to CAPTURE od Carreno, Joseph J., Lodise, Thomas P.

    Izdano 2014
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    COVID‐19: Important Therapy Considerations and Approaches in this Hour of Need

    COVID‐19: Important Therapy Considerations and Approaches in this Hour of Need od Lodise, Thomas P., Rybak, Michael J.

    Izdano 2020
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline

    Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline od Bidell, Monique R., Lodise, Thomas P.

    Izdano 2021
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Reply to “Successful Target Attainment of Telavancin at Elevated MICs: Fact or Fiction?”

    Reply to “Successful Target Attainment of Telavancin at Elevated MICs: Fact or Fiction?” od Lodise, Thomas P., Butterfield, Jill, Barriere, Steven

    Izdano 2012
    Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Prevalence of Invasive Infections Due to Carbapenem-Resistant Enterobacteriaceae among Adult Patients in U.S. Hospitals

    Prevalence of Invasive Infections Due to Carbapenem-Resistant Enterobacteriaceae among Adult Patients in U.S. Hospitals od Lodise, Thomas, Ye, Michael J., Zhao, Qi

    Izdano 2017
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Budget Impact Model of Omadacycline on Replacing a Proportion of Existing Treatment Options Among Patients Who Present to the Emergency Department with Acute Bacterial Skin and Skin Structure Infections

    Budget Impact Model of Omadacycline on Replacing a Proportion of Existing Treatment Options Among Patients Who Present to the Emergency Department with Acute Bacterial Skin and Ski... od LaPensee, Kenneth, Mistry, Rohit, Lodise, Thomas

    Izdano 2019
    Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Budget Impact of Omadacycline for the Treatment of Patients with Community-Acquired Bacterial Pneumonia in the United States from the Hospital Perspective

    Budget Impact of Omadacycline for the Treatment of Patients with Community-Acquired Bacterial Pneumonia in the United States from the Hospital Perspective od LaPensee, Kenneth, Mistry, Rohit, Lodise, Thomas

    Izdano 2019
    Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    The 30-Day Economic Burden of Newly Diagnosed Complicated Urinary Tract Infections in Medicare Fee-for-Service Patients Who Resided in the Community

    The 30-Day Economic Burden of Newly Diagnosed Complicated Urinary Tract Infections in Medicare Fee-for-Service Patients Who Resided in the Community od Lodise, Thomas P., Nowak, Michael, Rodriguez, Mauricio

    Izdano 2022
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    New Perspectives on Antimicrobial Agents: Imipenem-Relebactam

    New Perspectives on Antimicrobial Agents: Imipenem-Relebactam od O’Donnell, J. Nicholas, Lodise, Thomas P.

    Izdano 2022
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to Enterobacteriaceae: Results of a Systematic Literature Review and Meta-analysis

    Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to Enterobacteriaceae: Results of a Systematic Literature Rev... od Martin, Amber, Fahrbach, Kyle, Zhao, Qi, Lodise, Thomas

    Izdano 2018
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Safety of Delafloxacin: Focus on Adverse Events of Special Interest

    Safety of Delafloxacin: Focus on Adverse Events of Special Interest od Lodise, Thomas, Corey, Ralph, Hooper, David, Cammarata, Sue

    Izdano 2018
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    1928. Comparisons of 30-Day Admission and 30-Day Total Healthcare Costs Between Patients Who Were Treated With Oritavancin (ORI) or Vancomycin (VAN) for a Skin Infection in the Outpatient Setting

    1928. Comparisons of 30-Day Admission and 30-Day Total Healthcare Costs Between Patients Who Were Treated With Oritavancin (ORI) or Vancomycin (VAN) for a Skin Infection in the Out... od Lodise, Thomas, Packnett, Elizabeth, Armstrong, Shannon, Redell, Mark

    Izdano 2018
    Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Myelosuppression with Oxazolidinones: Are There Differences?

    Myelosuppression with Oxazolidinones: Are There Differences? od Hardalo, Cathy, Lodise, Thomas P., De Anda, Carisa

    Izdano 2018
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: